Cleared Traditional

K101662 - SYNAPSE 3D BASIC TOOLS

K101662 is the FDA 510(k) clearance for SYNAPSE 3D BASIC TOOLS by Fujifilm Medical System U.S.A., Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K101662 · Fujifilm Medical System U.S.A., Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
42d
Days
Class 2
Risk

K101662 is an FDA 510(k) clearance for the SYNAPSE 3D BASIC TOOLS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical System U.S.A., Inc. (Stamford, US). The FDA issued a Cleared decision on July 26, 2010 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical System U.S.A., Inc. devices

Submission Details

510(k) Number K101662 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 2010
Decision Date July 26, 2010
Days to Decision 42 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 107d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
CASEY CONRY

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1127
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K101662.
ENSITE VERISMO SEGMENTATION TOOL V.2.0
K101697 · St Jude Medical · Sep 2010
21.3 (54 CM) MONOCHROME DIGITAL MAMMOGRAPHY LCD MONITOR, MODEL MS3112 (MDL2128A)
K090947 · Totoku Electric Co., Ltd. · Aug 2010
SYNGO. PLAZA VA20A
K101666 · Siemens AG Medical Solutions · Aug 2010
CORONIS FUSION 10MP, MODEL MDCG-10130
K093197 · Barco N.V. · Jun 2010
SYMBIA.NET, SYMBIA.NET SELECT MODEL 10520828, 10520827
K100619 · Siemens Medical Solutions USA, Inc. · May 2010
SYNAPSE OBLIQUUS MIP/MPR/FUSION
K100881 · Fujifilm Medical System U.S.A., Inc. · Apr 2010